(Sharecast News) - EU regulators have recommended AstraZeneca's Imfinzi for approval in the treatment muscle-invasive bladder cancer (MIBC).
The recommendation by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency means that Imfinzi could be the first and only perioperative immunotherapy for adults with MIBC on...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE